This trial is testing whether pre-operative endocrine therapy helps inform decisions on whether or not to omit radiation for elderly women with early stage breast cancer scheduled for breast conservation surgery.
2 Primary · 15 Secondary · Reporting Duration: Through 24 months after start of adjuvant treatment period
83 Total Participants · 2 Treatment Groups
Primary Treatment: Patient reported outcomes · No Placebo Group · Phase 2
Age 65+ · Female Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: